Friday, 1 February 2013

Celsion's liver cancer therapy fails to meet late-stage trial goal

(Reuters) - Celsion Corp said a late-stage study of its experimental liver cancer treatment ThermoDox did not meet the main goal of increasing patients' survival without their cancer worsening. The study, named HEAT, was designed to show a 33 ...

Source: http://health.yahoo.net/news/s/nm/celsion-s-liver-cancer-therapy-fails-to-meet-late-stage-trial-goal

as explained here resource source here i found it

No comments:

Post a Comment

Note: only a member of this blog may post a comment.